Results 21 to 30 of about 620,469 (268)

Edible Rabies Vaccines [PDF]

Commercial Plant-Produced Recombinant Protein ProductsCase Studies, 2014
Rabies has been one of the most feared diseases throughout history. Human rabies remains an important public health problem in many developing countries. The WHO reports that more than 55,000 people die of this disease every year. Most of these cases occur in developing countries. In most Latin American countries, the major reservoirs of rabies are the
Loza-Rubio E, Rojas-Anaya E.
europepmc   +3 more sources

β-Glucan as Trained Immunity-Based Adjuvants for Rabies Vaccines in Dogs. [PDF]

Front Immunol, 2020
The mechanisms of trained immunity have been extensively described in vitro and the beneficial effects are starting to be deciphered in in vivo settings.
Paris S, Chapat L, Martin-Cagnon N, Durand PY, Piney L, Cariou C, Bergamo P, Bonnet JM, Poulet H, Freyburger L, De Luca K.   +10 more
europepmc   +2 more sources

Rabies Vaccine Protection Tests [PDF]

American Journal of Public Health and the Nations Health, 1934
J Reichel, Júlia Schneider
openalex   +5 more sources

Controlling Human Rabies: The Development of an Effective, Inexpensive and Locally Made Passive Cooling Device for Storing Thermotolerant Animal Rabies Vaccines. [PDF]

Trop Med Infect Dis, 2020
Thermotolerant vaccines greatly improved the reach and impact of large-scale vaccination programs to eliminate diseases such as smallpox, polio and rinderpest.
Lugelo A, Hampson K, Bigambo M, Kazwala R, Lankester F.   +4 more
europepmc   +2 more sources

Monophosphoryl-Lipid A (MPLA) is an Efficacious Adjuvant for Inactivated Rabies Vaccines. [PDF]

Viruses, 2019
Rabies, as one of the most threatening zoonoses in the world, causes a fatal central nervous system (CNS) disease. So far, vaccination with rabies vaccines has been the most effective measure to prevent and control this disease.
Chen C, Zhang C, Li R, Wang Z, Yuan Y, Li H, Fu Z, Zhou M, Zhao L.   +8 more
europepmc   +2 more sources

Generalized Modules for Membrane Antigens (GMMA), an outer membrane vesicle‐based vaccine platform, for efficient viral antigen delivery

Journal of Extracellular Vesicles, 2022
Vaccine platforms enable fast development, testing, and manufacture of more affordable vaccines. Here, we evaluated Generalized Modules for Membrane Antigens (GMMA), outer membrane vesicles (OMVs) generated by genetically modified Gram‐negative bacteria,
Kai Hu, Elena Palmieri, Karnyart Samnuan, Beatrice Ricchetti, Davide Oldrini, Paul F. McKay, Guanghui Wu, Leigh Thorne, Anthony R. Fooks, Lorraine M. McElhinney, Hooman Goharriz, Megan Golding, Robin J. Shattock, Francesca Micoli   +13 more
doaj   +1 more source

Modern approaches to production of safe and effective genetically modified rabies vaccines for animals

Ветеринария сегодня, 2023
Rabies is a dangerous zoonoticdisease that affects the central nervous system, causes encephalomyelitis and paralyses and Is almost invariably fatal.
M. I. Doronin, A. Mazloum, D. V. Mikhalishin, M. N. Mitrofanova, A. Yu. Sukharkov, V. V. Kiseleva, A. V. Sprygin   +6 more
doaj   +1 more source

New human rabies vaccines in the pipeline.

Vaccine, 2019
Fooks AR, Banyard AC, Ertl HCJ.
europepmc   +2 more sources

Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against reindeer rabies

Frontiers in Microbiology, 2022
The core element of the reindeer rabies eradication strategy is regular application of vaccines to obtain and uphold a vaccination coverage sufficient for the ceasing of rabies virus transmission.
Irina Matveeva, Olga Karpova, Nikolai Nikitin, Oleg Akilin, Vasiliy Yelnikov, Irina Litenkova, Roman Melnik, Nikolai Melnik, Karim Asimov, Aleksey Zaberezhny, Yriy Fyodorov, Evgeniya Markova   +11 more
doaj   +1 more source

BIOTECHNOLOGICAL RESEARCH IN THE CREATION AND PRODUCTION OF ANTIRABIC VACCINES [PDF]

Biotechnologia Acta, 2021
Rabies is a neurological disease of a viral nature, leading to death. Rabies virus is an RNA virus that invades the central nervous system, leading to neuronal dysfunction. Timely vaccination can prevent the diseases development. Aim.
Krasnopolsky Yu. М., Pylypenko D. М.
doaj